Find Academic Supervisors

Laura Elo serves as Professor of Computational Medicine and Head of the Medical Bioinformatics Centre at the University of Turku, Finland. She concurrently holds the position of Research Director at Turku Bioscience Centre and acts as InFLAMES Flagship Contact, driving interdisciplinary biomedical research initiatives. Her academic foundation includes a PhD in Applied Mathematics (2007) and Adjunct Professorship in Biomathematics (2011), establishing her quantitative expertise before transitioning into biomedical applications. Her research program focuses on transforming molecular and clinical datasets through statistical modeling and advanced machine learning . Key thrusts include robust computational tools for proteome/epigenome analysis, AI-driven digital health diagnostics, and computational systems immunology for immune-mediated diseases. This work directly addresses challenges in reproducibility and scalability of high-throughput biotechnology data. Analysis of her recent publications reveals dominant themes in type 1 diabetes biomarker discovery , multi-omics integration , and immune system modeling , with strong emphasis on clinical translation through collaborations with experimental and medical teams. Her scientific recognition includes: JDRF Career Development Award Professor Elo actively trains MSc/PhD students and postdoctoral fellows while leading major research initiatives including ERC grants. Her teaching portfolio spans Bioinformatics Journal Club, AI in Diagnostics, and Systems Biology courses. The Elo Lab (https://elolab.utu.fi) operates as a hub for computational biomedicine, developing open-source tools like CellRomeR while maintaining close ties with Turku Bioscience Centre's experimental facilities for validating computational predictions in immunology and metabolic disease contexts.

• Computational Biomedicine
• Medical Bioinformatics
• Data Science
• +7 more

Harri Lähdesmäki is an Associate Professor (tenured) at the Department of Computer Science, Aalto University, where he leads the Computational Systems Biology research group. His work focuses on probabilistic machine learning and deep generative models with applications in biomedicine and molecular biology. Key Research Interests: Probabilistic machine learning, deep generative models, computational biology, bioinformatics, longitudinal data modeling Contact: harri.lahdesmaki@aalto.fi | Konemiehentie 2, 02150 Espoo, Finland His recent publications highlight advancements in: Gaussian process priors for scalable deep generative models Single-cell analysis of immune repertoires in leukemia and diabetes Probabilistic deconvolution methods for RNA-seq data Epigenetic analysis using hidden Markov and mixed models Transformer-based survival prediction and missing data handling Harri’s work integrates mechanistic modeling with Bayesian inference, particularly applied to immunology, cancer biology, and early disease prediction.

• Probabilistic Machine Learning
• Deep Generative Models
• Artificial Intelligence
• +4 more

Sampsa Hautaniemi is a Professor at the Department of Biochemistry and Developmental Biology within the Faculty of Medicine at the University of Helsinki. He serves as Principal Investigator of the Systems Biology of Drug Resistance in Cancer research group and holds docentship in the Faculty of Medicine. Professor Hautaniemi actively supervises doctoral students across multiple programs including the Doctoral Programme in Biomedicine, Doctoral Programme in Clinical Research, and Doctoral Programme in Integrative Life Science. His research focuses on systems biology approaches to understand drug resistance mechanisms in cancer, particularly ovarian cancer. His work integrates computational biology, genomics, epigenetics, and bioinformatics to develop precision medicine approaches for cancer treatment. His laboratory develops innovative computational methods and experimental models including patient-derived organoids to study tumor evolution, identify therapeutic targets, and predict treatment responses. Analysis of his recent publications reveals a strong emphasis on understanding tumor heterogeneity, clonal evolution during therapy, and the development of computational tools for cancer genomics. His work spans multiple disciplines including cancer biology, computational biology, immunology, and precision medicine, with a particular focus on high-grade serous ovarian cancer as a model system. Scientific Awards: The Anders Jahre Medical Prize to young medical scientists (2014) for outstanding research on systems biology and cancer The Finnish Medical Foundation 50-years jubileum award (2010) Professor Hautaniemi has supervised numerous doctoral students and early-career researchers, contributing significantly to cancer research education. His research is supported by multiple active projects including the DECIDER project (Clinical Decision via Integrating Multiple Data Levels to Overcome Chemotherapy Resistance in High-Grade Serous Ovarian Cancer) funded until 2026, as well as projects from the Academy of Finland, Cancer Foundation, and industry partners like Orion Corporation. His laboratory maintains a patient-derived organoid biobank for high-grade serous ovarian cancer and develops computational tools like Jellyfish for visualizing tumor evolution.

• Systems Biology
• Cancer Research
• Drug Resistance
• +7 more

Ville Paavilainen is a Research Director at the Institute of Biotechnology, University of Helsinki, and supervisor for doctoral programs in Biomedicine and Integrative Life Science. With a postdoctoral background at the University of California, San Francisco (2008–2014), he focuses on Biochemistry , Cell Biology , and Molecular Biology , particularly mechanisms of protein translocation, membrane biology, and structural modeling. His research includes groundbreaking work on Sec61 translocon inhibition for cancer therapy and mitochondrial gene expression noise . Recent publications address lipid scrambling pathways, glioma stem cell targeting, and actin regulation. Active projects span EU-funded drug discovery and NIH collaborations. Key scientific contributions include Elucidating Sec61-client interactions Developing computational models for signal peptide prediction Uncovering mitochondrial-ER communication mechanisms He has supervised PhD theses (e.g., Paul Carlson) and contributed to over 39 research outputs. His work bridges structural biology, computational modeling, and translational pharmacology, with applications in tumor biology and neurodegenerative disease research.

• Biochemistry
• Cell Biology
• Molecular Biology
• +9 more

Mikko Hiltunen is a Professor of Tissue and Cell Biology at the Institute of Biomedicine, School of Medicine, University of Eastern Finland. His research focuses on molecular mechanisms of neurodegenerative disorders, particularly Alzheimer's disease and idiopathic normal pressure hydrocephalus (iNPH). He leads several research groups including the Molecular Genetics of Alzheimer's Disease (Hiltunen Lab) and participates in the Brain Research Unit and Genome Center of Eastern Finland. Research interests span Alzheimer's pathogenesis, neuroinflammation, genetic risk factors, biomarker discovery, and therapeutic development. His work integrates molecular biology, genetics, and clinical neuroscience to investigate microglial function, amyloid pathology, and cerebrospinal fluid biomarkers. Key areas include APOE genetics, PLCγ2-mediated neuroprotection, and machine learning applications in neurodegeneration. His recent publications demonstrate a strong focus on cerebrospinal fluid biomarkers, genetic association studies, neuroinflammation mechanisms, and therapeutic interventions. Article themes consistently emphasize microglial biology, genetic risk modifiers, and translational approaches for Alzheimer's and iNPH. Collaborative projects include Neuro-Innovation (2021-2026) and NOVEL MSCA Postdoctoral Programme (2024-2029). Hiltunen leads the Clinical Alzheimer Research group and co-directs the UEF Brain Research Unit. His team utilizes advanced models including iPSC-derived microglia and pericyte systems to study neurovascular interactions. Current work explores phospho-tau immunotherapy, lysosomal dysfunction, and polygenic risk score applications across diverse populations.

• Alzheimer's Disease
• Neurodegeneration
• Molecular Genetics
• +3 more

Juan Valle Delgado is a Lecturer in the Department of Bioproducts and Biosystems at Aalto University, where he focuses on nanotechnology, biomaterials, and interfacial science. His research explores sustainable materials derived from biopolymers like cellulose and lignin, with applications in biomedicine, green chemistry, and advanced composites. Research Interests: Dr. Delgado's work spans atomic force microscopy, nanocellulose functionalization, colloidal systems, and surface chemistry. Key themes include: Design of lignin nanoparticles for drug delivery and 3D bioprinting Cellulose nanofibril hydrogels for biomedical applications Interfacial interactions in bio-based composites Surface modification techniques for sustainable materials His recent publications (2019–2023) demonstrate a strong emphasis on biomaterial interfaces , with recurring studies on cellulose-lignin systems, nanoparticle synthesis, and cell-biomaterial interactions. Collaborative projects frequently involve tissue engineering, cancer research, and green nanotechnology. Dr. Delgado collaborates extensively with the Bioproduct Chemistry research group, focusing on interdisciplinary approaches to develop functional materials from renewable resources.

• Nanotechnology
• Biomaterials
• Surface Chemistry
• +7 more

Itana Bojovic is a Project researcher at Turku Life Science Center and Doctoral Researcher in the Department of Biomedicine at University of Turku. She is a member of Elo Lab specializing in Computational Biomedicine. Her research focuses on immunology, particularly T cell biology using single-cell analysis techniques. Her work bridges computational methods with biological research to create comprehensive T cell atlases. Bojovic's research, exemplified by her 2025 publication in Immunology and Cell Biology, demonstrates expertise in single-cell technologies, computational biology, and immune system modeling. Her work contributes to understanding T cell differentiation and immune cell profiling. She collaborates with researchers including António GG. Sousa, Blue Junttila, and Laura L. Elo, with whom she co-authored her recent publication.

• Immunology
• T cells
• Single-cell analysis
• +1 more

Pauliina Ilmonen is an Associate Professor and Vice Dean in the Department of Mathematics and Systems Analysis at Aalto University, within the School of Science. Her research focuses on mathematical statistics, probability theory, and data science, with applications in healthcare and engineering. She holds academic positions in both the Department of Mathematics and Systems Analysis and Statistics and Mathematical Data Science. Her work spans statistical methodology, stochastic processes, and interdisciplinary collaborations in biomedicine. Notable research areas include extreme value analysis, functional data analysis, and the modeling of dependent data. She has contributed to studies on HIV transmission dynamics, prostate cancer genomics, and the statistical analysis of infectious diseases. Dr. Ilmonen’s recent publications (2020–2025) emphasize methodological advancements in statistical inference, computational statistics, and applications in healthcare. She leads projects on predictive modeling, cost-effectiveness analysis in cancer screening, and network traffic prediction. Her findings bridge theoretical statistics with practical challenges in medicine and technology. She advises 8 theses and collaborates on grants exploring mathematical data science, biostatistics, and stochastic systems. Active in academic service, she contributes to curriculum development and promotes ethical use of statistics in research.

• Mathematical Statistics
• Probability Theory
• Data Science
• +3 more

Ravi Kant serves as Principal Investigator and Adjunct Associate Professor at the University of Helsinki, with additional Visiting Professor appointments at Medical University of Gdansk, Poland and University of Nairobi, Kenya. He is affiliated with the Helsinki One Health (HOH) Viral Zoonosis Research Unit and the Emerging Infections Research Group within the Department of Virology at the Faculty of Medicine. His research focuses on viral zoonoses, emerging infectious diseases, and viral genomics. Key research areas include SARS-CoV-2 transmission dynamics, viral pathogenesis in animal models, viral metagenomics, and molecular epidemiology of emerging pathogens. His work spans both human and veterinary medicine, reflecting the One Health approach that characterizes his research unit. Kant leads multiple significant research projects including the EU-funded REFINE project (2025-2028), Pipeline for Rapid Diagnostics of Emergency Transboundary Infectious Diseases (2023-2027), and research on poxvirus epidemiology and disease control (2022-2025). His publication record demonstrates consistent output with 81 publications spanning from 2005 to 2025, with recent emphasis on SARS-CoV-2, mpox, antimicrobial resistance, and viral metagenomics. He actively supervises doctoral students across multiple programs including Biomedicine, Microbiology and Biotechnology, and Clinical Veterinary Medicine, with several ongoing doctoral supervision activities documented through 2025. His media engagement includes significant contributions to public understanding of infectious diseases, with appearances discussing topics such as the cause of dermatitis epidemics in trotting horses, innovative mobile diagnostic laboratories, and mitochondrial roles in antiviral immunity.

• Virology
• Zoonotic Diseases
• Infectious Diseases
• +5 more

Anna Vähärautio is an Adjunct Professor at the University of Helsinki, affiliated with the Organismal and Evolutionary Biology Research Programme. She supervises the Doctoral Programme in Integrative Life Science and the Doctoral Programme in Biomedicine. Her research focuses on cancer genomics, drug resistance mechanisms, and single-cell transcriptomics in ovarian cancer. She leads multiple funded projects, including a €1.99M ERC grant (2024–2029) for studying cancer resistance, and collaborates extensively on initiatives like the iCAN Digital Precision Cancer Medicine flagship. Her work employs advanced genomic techniques to identify therapeutic vulnerabilities in ovarian cancer. Dr. Vähärautio organizes academic events such as the Single Cell Transcriptomics Symposium and Eurooppalainen tutkijoiden yö (European Researchers' Night).

• Cancer Genomics
• Ovarian Cancer
• Drug Resistance
• +2 more

Ping Chen is an Academy Research Fellow at the University of Helsinki , affiliated with the Faculty of Medicine and the Stem Cells and Metabolism Research Program . They also hold an Assistant Professor position at Karolinka Institutet since 2021. Research Interests: Biomedical research focusing on stem cells and metabolism Medical biotechnology applications in disease mechanisms Single-cell RNA sequencing and transcriptomics Alternative splicing and gene regulation in cancer Computational methods for sparse data analysis MicroRNA functions in tumor sensitivity Scientific Contributions: Their recent work spans epithelial cell dynamics in organ development, liver immunology in metabolic diseases, glioblastoma signaling pathways, and computational frameworks for cancer subtyping. Articles show strong integration of bioinformatics , genomics , and translational medicine . Awards and Grants: Academy Research Fellow, Research Council of Finland Docent (adjunct professor) title in the Faculty of Medicine Juselius 1-3 Chen 25 project (2024-2026) funded by Sigrid Juséliuksen Säätiö Academy of Finland grant (2023-2027) for studying RNA editing and macrophage plasticity in metabolic diseases Collaborative Network: Active collaborations include researchers from Massachusetts Institute of Technology, Nordic Lymphoma Group, and multiple European institutions.

• Biomedicine
• Medical biotechnology
• Stem cell research
• +4 more

Leena Lauronen is an Assistant Professor at the Department of Neurosciences , University of Helsinki , and a supervisor in the Doctoral Programme Brain & Mind and Doctoral Programme in Biomedicine . She works within the BioMag Laboratory under HUS Physiology, Genetics and Preanalytics , focusing on HUS Children's and Adolescent Diseases . Her research integrates neurosciences and clinical neurophysiology to study brain development from infancy to adolescence, particularly in preterm and neurodevelopmentally at-risk populations. She employs advanced techniques like EEG and ECG-derived tachograms to map brain function trajectories and explores spinal cord plasticity in response to cortical stimulation. Recent work includes epilepsy surgery diagnostics and neurodevelopmental assessment tools . Dr. Lauronen’s publications reveal a focus on neurodevelopmental disorders , pediatric neurology , and biomedical signal processing . Her methodological expertise spans stereoelectroencephalography , transcranial magnetic stimulation , and machine learning applications in neurology.

• Neurosciences
• Child Neurology
• Clinical Neurophysiology
• +5 more

Maria Vartiainen serves as Research Director at the Institute of Biotechnology, University of Helsinki, where she leads groundbreaking research on nuclear organization by actin. She supervises doctoral students in both the Doctoral Programme in Biomedicine and the Doctoral Programme in Integrative Life Science, contributing significantly to the training of next-generation scientists in molecular and cellular biology. Her research interests focus on the molecular mechanisms of nuclear actin in transcription regulation and gene expression. Vartiainen's work has revealed critical insights into how actin dynamics influence chromatin organization, transcription factor activity, and nuclear architecture. She investigates the roles of actin in MRTF-SRF signaling pathways, nuclear lamina organization, and the regulation of RNA polymerase II during transcription elongation, with implications for understanding both normal cellular processes and disease mechanisms. Analysis of her recent publications shows a consistent trajectory in understanding nuclear actin's multifaceted roles, with increasing focus on therapeutic applications, particularly in cancer research and viral-host interactions as evidenced by her SARS-CoV-2 hijackome knowledge base project. Her work bridges fundamental cell biology with potential clinical applications. Scientific Recognition: Loreal for Women in Science Award (2014) Vartiainen has secured substantial research funding from the Academy of Finland, including as Project Manager for the FIRI2024 EuBI HY project (2025-2027) with €1,075,181.30 in funding, and as a key participant in the InterEarth RESET project (2023-2028). She directs the Light Microscopy Technology Platform at the Institute of Biotechnology, providing essential imaging resources for the research community.

• Molecular Biology
• Cell Biology
• Nuclear Organization
• +3 more

Mehrad Mahmoudian serves as a Doctoral Researcher in the Department of Computing and Project Researcher at the Institute of Biomedicine, University of Turku. He is affiliated with the Computational Biomedicine research group under Elo Lab, operating from Biocity 7th floor (Office 7096) at Tykistökatu 6, Turku. His research spans Machine Learning , Statistical Data Analysis , and Survival Analysis applied to biomedical challenges. Key focus areas include cancer genomics, reproductive health disorders, microbiome analysis, and clinical risk prediction. His methodological innovations address high-dimensional biological data through algorithm development for feature selection, epigenomic analysis, and predictive modeling. Analysis of his publications reveals a consistent trajectory in developing computational tools for biomedical data interpretation. His work bridges molecular biology (epigenetics, transcriptomics) with clinical applications (cancer prognosis, pregnancy disorders, cardiovascular risk), emphasizing robust statistical frameworks and machine learning pipelines for translational research. As a core member of the Computational Biomedicine group, he contributes to collaborative projects involving multi-omics integration, clinical decision support systems, and biomarker discovery. His technical expertise spans proteomics, metaproteomics, and genomic data analysis pipelines, with significant contributions to open-source computational methods like ROTS for differential peak detection.

• Machine Learning
• Statistical Data Analysis
• Survival Analysis
• +2 more

Anja Hartewig is a Doctoral Researcher at Tampere University, Faculty of Medicine and Health Technology, Department of Biomedicine. Her work bridges biochemistry and bioinformatics with a mission to understand the epigenetic drivers of malignancy in brain tumors, particularly diffuse gliomas. Her research interests center on the epigenetic mechanisms underlying brain tumor progression. With a strong foundation in both experimental biochemistry and computational analysis, she applies bioinformatics approaches to decode molecular signatures in gliomas. This interdisciplinary focus enables her to explore how epigenetic alterations contribute to tumor aggressiveness and therapeutic resistance. Anja completed her B.Sc. in Biochemistry and M.Sc. in Biomedicine at Leipzig, Germany, before moving to Tampere University to specialize in bioinformatics and pursue her doctoral studies. Her trajectory reflects a deliberate integration of wet-lab and dry-lab methodologies in cancer research. She is actively engaged in research but no publications or scientific awards are listed in the available information. There is no mention of students she may be supervising or mentoring. She is based at the Kauppi Campus and maintains an ORCID profile (0000-0003-0539-4857), indicating active scholarly engagement.

• Epigenetics
• Brain Tumors
• Diffuse Gliomas
• +5 more